(Bloomberg) -- The US Supreme Court left in place a $65 million antitrust judgment against Martin Shkreli ... to control the ...

Martin Shkreli, the notorious former CEO ... found Shkreli and his companies made from jacking up the price of Daraprim. Shkreli was ordered to repay that sum to the states that joined the FTC ...

Why do they call Martin shkreli Pharma Bro? Mr. Shrkeli played a major role in driving up the price of Daraprim, a toxoplasmosis drug, which the Swiss company owns the rights to, earning him the ...

An curved arrow pointing right. Martin Shkreli, the controversial pharmaceutical CEO and hedge funder, who was heavily criticized for raising the price of a life-saving drug by 500%, has been ...

A pharma company formerly led by 'pharma bro' Martin Shkreli has ... which said that Shkreli masterminded the scheme to fleece patients dependent on Daraprim. His company not only raised the ...

Jury selection kicked off Monday in New York for the next chapter of a federal securities trial that could open up the cell adjoining convicted fraudster Martin ... Shkreli is best known for his ...

Former pharma executive Martin Shkreli, who became notorious for raising ... which hiked the price of off-patent HIV drug Daraprim (pyrimethamine) from $13.50 to $750 per tablet – leaving ...

Below are the recipients of the 2024 Shkreli Award, as decided by the Lown Institute.

The annual awards are named after "pharma bro" Martin Shkreli, who was sentenced to ... rights to the anti-parasitic drug pyrimethamine (Daraprim), whose price he marked up by more than 5,000% ...

3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed. 3D medical animation ...

Controversial figure Martin Shkreli issued a stark warning for Bitcoin (CRYPTO: BTC) proxy stock, MicroStrategy ...

A New York federal judge ordered Martin Shkreli to surrender any copies of ... fixing scheme to maintain their monopoly over Daraprim. U.S. News // 5 years ago Appeals court upholds Martin ...